Shareholding disclosure

senior management and board of directors

Declared position

3.8%

Threshold

Crossed upwards

Timeline

Published

04.10.2017

Transaction

25.09.2017

Voting rights breakdown

Voting rights acquired3.8%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

TBH9T00021

Beneficial owner

senior management and board of directors

Declared address

senior management and board of directors

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

senior management and board of directors

Newron Pharmaceuticals S.p.A.04.10.2017TBH9T00021

Disclosure summary

senior management and board of directors disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 04.10.2017, at 3.8% of voting rights. Notice category: Group of shareholders.

Disclosed position

3.8%

Voting rights acquired

Voting rights acquired3.8%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

senior management and board of directors disclosed a holding in Newron Pharmaceuticals S.p.A., published on 04.10.2017.

Publication date04.10.2017

Transaction date25.09.2017

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownersenior management and board of directors

Declared addresssenior management and board of directors

CategoryGroup of shareholders

Voting rights acquired3.8%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTBH9T00021

Source: SIX Exchange Regulation · Publication date: 04.10.2017

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open